High Intensity Interval Circuit Training on Resting Metabolic Rate in Overweight Adults
The Effect of High Intensity Interval Circuit Training With Portable Equipment on Changes in Resting Metabolic Rate in Overweight Adults
1 other identifier
interventional
20
1 country
1
Brief Summary
This is the first study to examine changes in resting metabolic rate up to 72 hours following an exercise session, and how these changes may be affected by 12 weeks of high intensity interval circuit training (HIICT). Various training programs that have been implemented in previous studies have investigated changes in resting metabolic rate only for the first 2-8 hours following an exercise session. Briefly, the results of this study will provide insight into the following:
- 1.To what extent and for how long does HIICT increases the resting metabolic rate following an exercise session?
- 2.How can this exercise program enhance metabolism without any dietary or other exercise intervention?
- 3.What is the caloric deficit that will result from 3 months of HIICT and how to what extent this deficit will influence body weight reduction?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Apr 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 8, 2019
CompletedFirst Submitted
Initial submission to the registry
May 23, 2019
CompletedFirst Posted
Study publicly available on registry
June 3, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 20, 2019
CompletedNovember 6, 2019
November 1, 2019
3 months
May 23, 2019
November 4, 2019
Conditions
Outcome Measures
Primary Outcomes (8)
Resting metabolic rate (kilocalories)
Resting metabolic rate following 12 hours of an overnight fast
At baseline
Resting metabolic rate (24 before an exercise bout) (kilocalories)
Changes in resting metabolic rate 24 before an exercise bout
Pre-intervention, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Resting metabolic rate (24 following an exercise bout) (kilocalories)
Changes in resting metabolic rate 24 following an exercise bout
Pre-intervention, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Resting metabolic rate (48 following an exercise bout) (kilocalories)
Changes in resting metabolic rate 48 following an exercise bout
Pre-intervention, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Resting metabolic rate (72 following an exercise bout) (kilocalories)
Changes in resting metabolic rate 72 following an exercise bout
Pre-intervention, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Body fat mass (kilograms)
Changes in body fat mass measured with dual-energy x-ray absorptiometry (DEXA)
At baseline, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Body lean mass (kilograms)
Changes in body lean mass measured with dual-energy x-ray absorptiometry (DEXA)
At baseline, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Bone mass (kilograms)
Changes in bone mass measured with dual-energy x-ray absorptiometry (DEXA)
At baseline, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Secondary Outcomes (5)
Waist to hip ratio (WHR)
At baseline, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Lower limb strength
At baseline, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Upper body strength
At baseline, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Aerobic capacity test
At baseline, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Maximal abdominal muscle endurance
At baseline, 24 hours after completion of phase 1, 24 hours after completion of phase 2, 24 hours after completion of phase 3
Study Arms (2)
Experimental group
EXPERIMENTALA 12-week high intensity interval circuit training program for weight management in overweight adults.
Control group
NO INTERVENTIONNo intervention for 12 weeks, participants perform all tests.
Interventions
Phase 1 is the first 4 weeks of the 12-week training program.
Phase 2 is the next 4 weeks following phase 1 of the 12-week training program. The exercise intensity during exercise bouts in this phase is increased compared to the exercise intensity applied in phase 1.
Phase 3 is the last 4 weeks of the 12-week training program. The exercise intensity during exercise bouts in this phase is increased compared to the exercise intensity applied in the previous phases.
Eligibility Criteria
You may qualify if:
- Overweight or class I obesity (BMI: 25-35 kg/m\^2)
- Sedentary lifestyle
- Willing to lose weight
- Individuals at low risk of various cardiovascular, pulmonary, renal, and metabolic diseases as well as other conditions (e.g., pregnancy and orthopedic injury) that require special attention when developing the exercise prescription (Thompson et al., 2013). This risk classification indicates that participants will be able to participate in moderate intensity exercise \[40-60% oxygen uptake reserve (VO2R); 3-6 metabolic equivalent of task (METs)\] and also in vigorous intensity exercise (\>60% VO2R; \>6 METs) while medical examination, exercise test and physician supervision are not recommended in the preparticipation health screening process.
You may not qualify if:
- Following a diet plan or taking dietary supplements over the last 6 months and during the intervention
- Participation in another training program over the last 6 months and during the intervention
- Family history of coronary heart disease
- Recent musculoskeletal injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SmArT LABORATORY, SCHOOL OF PHYSICAL EDUCATION & SPORTS SCIENCES, UNIVERSITY OF THESSALY
Trikala, 42100, Greece
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Ioannis G Fatouros, PhD
SmArT Lab, DPESS, University of Thessaly
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 23, 2019
First Posted
June 3, 2019
Study Start
April 8, 2019
Primary Completion
July 20, 2019
Study Completion
August 20, 2019
Last Updated
November 6, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share